Raludotatug Deruxtecan Shows Activity in Platinum-Sensitive Ovarian Cancer Raludotatug deruxtecan showed promising clinical activity in patients with heavily pretreated, platinum-sensitive ovarian cancer.

Raludotatug Deruxtecan Shows Activity in Platinum-Sensitive Ovarian Cancer @stephensoncancer.bsky.social @myesmo.bsky.social #ESMOGynae25 #oncolology www.onclive.com/view/raludot...